Biomarkers and Surrogate Endpoints for Normal-Tissue Effects of Radiation Therapy: The Importance of Dose–Volume Effects

This publication has 35 references indexed in Scilit:

• Surrogate End Points for Median Overall Survival in Metastatic Colorectal Cancer: Literature-Based Analysis From 39 Randomized Controlled Trials of First-Line Chemotherapy
  Journal of Clinical Oncology, 2007
• A Genetically Determined Dose–Volume Histogram Predicts for Rectal Bleeding among Patients Treated With Prostate Brachytherapy
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
• Genome-wide association study identifies novel breast cancer susceptibility loci
  Nature, 2007
• Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
  Nature, 2007
• Erythropoietin: High Profile, High Scrutiny
  Journal of Clinical Oncology, 2007
• Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
  Nature Reviews Cancer, 2006
• Does transforming growth factor-β1 predict for radiation-induced pneumonitis in patients treated for lung cancer?
  Cytokine, 2006
• Association of DNA Repair and Steroid Metabolism Gene Polymorphisms with Clinical Late Toxicity in Patients Treated with Conformal Radiotherapy for Prostate Cancer
  Clinical Cancer Research, 2006
• Interleukin (IL)-1A and IL-6: Applications to the predictive diagnostic testing of radiation pneumonitis
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
• The Relation Between Tumour Lethal Doses and the Radiosensitivity of Tumour Cells
  British Journal of Radiology, 1961